Floatz logo

Immunoglobulin G1-Lambda2, Anti-(Severe Acute Respiratory Syndrome (Human) Coronavirus 2 (Sars-Cov-2) Spike (S) Glycoprotein, Receptor Binding Domain (Rbd)), Homo Sapiens Monoclonal Antibod

Thrombotic Thrombocytopenic Purpura

Imperial College Healthcare NHS Trustmonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Thrombotic Thrombocytopenic Purpura cohort.

Asset / SponsorPhaseRating
Ogalvibart
Imperial College Healthcare NHS Trust
Phase 2CCC
Pyrrotini
Tianjin Medical University Cancer Institute and Hospital
Phase 4NR

Same molecule, other indications

Immunoglobulin G1-Lambda2, Anti-(Severe Acute Respiratory Syndrome (Human) Coronavirus 2 (Sars-Cov-2) Spike (S) Glycoprotein, Receptor Binding Domain (Rbd)), Homo Sapiens Monoclonal Antibod is also rated in:

COVID-19Active
CCC
Indicative · Phase 2
53 / 100
View asset →
plasma cell myelomaActive
CCC
Indicative · Phase 2
53 / 100
View asset →
thrombocytopenia due to immune destructionActive
CCC
Indicative · Phase 2
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →